Clinical and angiographic outcome
| All (n = 170) | Center A (n = 57) | Center B (n = 42) | Center C (n = 44) | Center D (n = 27) | |
|---|---|---|---|---|---|
| Clinical outcome | |||||
| NIHSS at discharge (median) (range) | 6 (3–12) | 6 (3–11) | 8 (4–15) | 8 (3–15) | 5 (2–10) |
| FU mRS ≤ 2 | 62/170 (36%) | 22/57 (39%) | 16/42 (38%) | 15/44 (34%) | 9/27 (33%) |
| In-hospital mortality (all cause) | 32/170 (19%) | 11/57 (19%) | 5/42 (12%) | 9/44 (20%) | 7/27 (26%) |
| PH1 (n/N) (%) | 13/170 (8%) | 4/57 (7%) | 2/42 (5%) | 5/44 (11%) | 2/27 (7%) |
| PH2 (n/N) (%) | 11/170 (6%) | 5/57 (7%) | 2/42 (5%) | 1/44 (2%) | 3/27 (11%) |
| sICH (n/N) (%) | 15/170 (9%) | 5/57 (9%) | 3/42 (7%) | 3/44 (7%) | 4/27 (15%) |
| Angiographic outcome | |||||
| Groin puncture to recanalization (min) (median) (range) | 88 (59–121) | 75 (56–95) | 81 (41–118) | 111 (70–148) | 119 (84–147) |
| Symptom onset to recanalization (min) (median) (range) | 296 (236–367) | 263 (217–317) | 332 (259–401) | 317 (252–420) | 306 (227–365) |
| TICI ≥ 2b (n/N) (%) | 130/170 (77%), 113/133 (85%)b | 48/57 (84%) | 22/42 (53%)a | 36/44 (82%) | 24/27 (89%) |
| TICI 2a (n/N) (%) | 21/170 (12%) | 3/57 (5%) | 13/42 (31%) | 4/44 (9%) | 1/27 (4%) |